1. Pristimerin in Oxidative Stress and Use in Cancer
    Ana Carolina B. da C. Rodrigues et al, 2021, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
  2. bta-miR-23a Regulates the Myogenic Differentiation of Fetal Bovine Skeletal Muscle-Derived Progenitor Cells by Targeting MDFIC Gene
    Xin Hu et al, 2020, Genes CrossRef
  3. Focusing on the Role of Natural Products in Overcoming Cancer Drug Resistance: An Autophagy-Based Perspective
    Jiaqi Yao et al, 2022, Biomolecules CrossRef
  4. Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy
    Huaji Jiang et al, 2024, Autophagy CrossRef
  5. ATTEMPTS TO SYNTHESIZE A TRIMERIC DERIVATIVE OF PRISTIMERIN WITH POTENTIAL ACTIVITY AGAINST CANCER CELLS
    Josana Pereira Dos Santos et al, 2024, Revista Contemporânea CrossRef
  6. A Link Between Chemical Structure and Biological Activity in Triterpenoids
    Cunqin Wang et al, 2022, Recent Patents on Anti-Cancer Drug Discovery CrossRef
  7. Pristimerin in Oxidative Stress and Use in Cancer
    Ana Carolina B. da C. Rodrigues et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
  8. The mechanism and application of traditional Chinese medicine extracts in the treatment of lung cancer and other lung-related diseases
    Zhenglin He et al, 2023, Frontiers in Pharmacology CrossRef
  9. Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer
    Karen Yamaguchi et al, 2022, Biomolecules CrossRef
  10. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
    Maria Konoshenko et al, 2022, International Journal of Molecular Sciences CrossRef
  11. Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy
    Chao Chen et al, 2022, Nano Convergence CrossRef
  12. Neuroplasticity to autophagy cross-talk in a therapeutic effect of physical exercises and irisin in ADHD
    Alhasan Abdulghani et al, 2023, Frontiers in Molecular Neuroscience CrossRef
  13. Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
    Jia-jun Li et al, 2019, Frontiers in Pharmacology CrossRef
  14. Berbamine Hydrochloride inhibits lysosomal acidification by activating Nox2 to potentiate chemotherapy-induced apoptosis via the ROS-MAPK pathway in human lung carcinoma cells
    Yujuan Zhan et al, 2023, Cell Biology and Toxicology CrossRef
  15. Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
    Run-Ze Chen et al, 2021, Frontiers in Oncology CrossRef
  16. Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
    Bartosz Mateusz Gąsiorkiewicz et al, 2021, Investigational New Drugs CrossRef